James Burns is the founder of Locanabio. Locanabio has raised $155M in total funding. Latest round: Series B. Based in San Diego, CA.
Jim Burns is the CEO of Locanabio, a San Diego-based gene therapy firm that developed RNA-targeted gene therapies for genetic neuromuscular and neurodegenerative diseases. The company was founded in 2016 out of the University of San Diego and secured over $150 million in venture funding, including a $55 million Series A and a $100 million Series B. Locanabio announced its closure by the end of 2023 due to the time and capital required for clinical data in a challenging funding environment.
Full founder directory · Investor directory · Company funding database · Fundraising library